Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling

Misuzu Yamashita, Fumio Otsuka, Tomoyuki Mukai, Ryutaro Yamanaka, Hiroyuki Otani, Yoshinori Matsumoto, Eri Nakamura, Mariko Narazaki, Kenei Sada, Hirofumi Makino

Research output: Contribution to journalArticlepeer-review

76 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds